cAMP protects endothelial barrier functions by preventing Rac-1 inhibition

J. Waschke, D. Drenckhahn, R. H. Adamson, H. Barth, F. E. Curry

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

cAMP enhances endothelial barrier properties and is protective against various inflammatory mediators both in vivo and in vitro. However, the mechanisms whereby cAMP stabilizes the endothelial barrier are largely unknown. Recently we demonstrated that the Rho family GTPase Rac-1 is required for maintenance of endothelial barrier functions in vivo and in vitro. Therefore, in the present study we investigated the effect of forskolin (5 μM)- and rolipram (10 μM)-induced cAMP increase on reduction of barrier functions in response to Rac-1 inhibition by Clostridium sordellii lethal toxin (LT). Forskolin and rolipram treatment blocked LT (200 ng/ml)-induced hydraulic conductivity (Lp) increase in mesenteric microvessels in vivo. Likewise, LT-induced intercellular gap formation in monolayers of cultured microvascular myocardial endothelial (My-End) cells and LT-induced loss of adhesion of vascular endothelial cadherin-coated microbeads were abolished. Inhibition of PKA by myristoylated inhibitor peptide (14-22) of PKA (100 μM) reduced the protective effect of cAMP on LT-induced Lp increase in vivo and gap formation in vitro, indicating that the effect of cAMP on Rac-1 inhibition was PKA dependent. Glucosylation assays demonstrated that cAMP prevents inhibitory Rac-1 glucosylation by LT, indicating that one way that cAMP enhances endothelial barrier functions may be by regulating Rac-1 signaling. Our study suggests that cAMP may provide its well-established protective effects at least in part by regulation of Rho proteins.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume287
Issue number6 56-6
DOIs
StatePublished - Dec 2004

Fingerprint

Rolipram
Colforsin
rho GTP-Binding Proteins
Microvessels
Microspheres
Endothelial Cells
Maintenance
Peptides
In Vitro Techniques
Proteins
protein kinase modulator
Clostridium sordellii lethal toxin LT
cadherin 5

Keywords

  • cAMP-dependent protein kinase
  • Permeability
  • Rho proteins
  • Vascular endothelial cadherin

ASJC Scopus subject areas

  • Physiology

Cite this

cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. / Waschke, J.; Drenckhahn, D.; Adamson, R. H.; Barth, H.; Curry, F. E.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 287, No. 6 56-6, 12.2004.

Research output: Contribution to journalArticle

Waschke, J. ; Drenckhahn, D. ; Adamson, R. H. ; Barth, H. ; Curry, F. E. / cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. In: American Journal of Physiology - Heart and Circulatory Physiology. 2004 ; Vol. 287, No. 6 56-6.
@article{2dcf54d614774269a56d9ce9cc76e359,
title = "cAMP protects endothelial barrier functions by preventing Rac-1 inhibition",
abstract = "cAMP enhances endothelial barrier properties and is protective against various inflammatory mediators both in vivo and in vitro. However, the mechanisms whereby cAMP stabilizes the endothelial barrier are largely unknown. Recently we demonstrated that the Rho family GTPase Rac-1 is required for maintenance of endothelial barrier functions in vivo and in vitro. Therefore, in the present study we investigated the effect of forskolin (5 μM)- and rolipram (10 μM)-induced cAMP increase on reduction of barrier functions in response to Rac-1 inhibition by Clostridium sordellii lethal toxin (LT). Forskolin and rolipram treatment blocked LT (200 ng/ml)-induced hydraulic conductivity (Lp) increase in mesenteric microvessels in vivo. Likewise, LT-induced intercellular gap formation in monolayers of cultured microvascular myocardial endothelial (My-End) cells and LT-induced loss of adhesion of vascular endothelial cadherin-coated microbeads were abolished. Inhibition of PKA by myristoylated inhibitor peptide (14-22) of PKA (100 μM) reduced the protective effect of cAMP on LT-induced Lp increase in vivo and gap formation in vitro, indicating that the effect of cAMP on Rac-1 inhibition was PKA dependent. Glucosylation assays demonstrated that cAMP prevents inhibitory Rac-1 glucosylation by LT, indicating that one way that cAMP enhances endothelial barrier functions may be by regulating Rac-1 signaling. Our study suggests that cAMP may provide its well-established protective effects at least in part by regulation of Rho proteins.",
keywords = "cAMP-dependent protein kinase, Permeability, Rho proteins, Vascular endothelial cadherin",
author = "J. Waschke and D. Drenckhahn and Adamson, {R. H.} and H. Barth and Curry, {F. E.}",
year = "2004",
month = "12",
doi = "10.1152/ajpheart.00556.2004",
language = "English (US)",
volume = "287",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 56-6",

}

TY - JOUR

T1 - cAMP protects endothelial barrier functions by preventing Rac-1 inhibition

AU - Waschke, J.

AU - Drenckhahn, D.

AU - Adamson, R. H.

AU - Barth, H.

AU - Curry, F. E.

PY - 2004/12

Y1 - 2004/12

N2 - cAMP enhances endothelial barrier properties and is protective against various inflammatory mediators both in vivo and in vitro. However, the mechanisms whereby cAMP stabilizes the endothelial barrier are largely unknown. Recently we demonstrated that the Rho family GTPase Rac-1 is required for maintenance of endothelial barrier functions in vivo and in vitro. Therefore, in the present study we investigated the effect of forskolin (5 μM)- and rolipram (10 μM)-induced cAMP increase on reduction of barrier functions in response to Rac-1 inhibition by Clostridium sordellii lethal toxin (LT). Forskolin and rolipram treatment blocked LT (200 ng/ml)-induced hydraulic conductivity (Lp) increase in mesenteric microvessels in vivo. Likewise, LT-induced intercellular gap formation in monolayers of cultured microvascular myocardial endothelial (My-End) cells and LT-induced loss of adhesion of vascular endothelial cadherin-coated microbeads were abolished. Inhibition of PKA by myristoylated inhibitor peptide (14-22) of PKA (100 μM) reduced the protective effect of cAMP on LT-induced Lp increase in vivo and gap formation in vitro, indicating that the effect of cAMP on Rac-1 inhibition was PKA dependent. Glucosylation assays demonstrated that cAMP prevents inhibitory Rac-1 glucosylation by LT, indicating that one way that cAMP enhances endothelial barrier functions may be by regulating Rac-1 signaling. Our study suggests that cAMP may provide its well-established protective effects at least in part by regulation of Rho proteins.

AB - cAMP enhances endothelial barrier properties and is protective against various inflammatory mediators both in vivo and in vitro. However, the mechanisms whereby cAMP stabilizes the endothelial barrier are largely unknown. Recently we demonstrated that the Rho family GTPase Rac-1 is required for maintenance of endothelial barrier functions in vivo and in vitro. Therefore, in the present study we investigated the effect of forskolin (5 μM)- and rolipram (10 μM)-induced cAMP increase on reduction of barrier functions in response to Rac-1 inhibition by Clostridium sordellii lethal toxin (LT). Forskolin and rolipram treatment blocked LT (200 ng/ml)-induced hydraulic conductivity (Lp) increase in mesenteric microvessels in vivo. Likewise, LT-induced intercellular gap formation in monolayers of cultured microvascular myocardial endothelial (My-End) cells and LT-induced loss of adhesion of vascular endothelial cadherin-coated microbeads were abolished. Inhibition of PKA by myristoylated inhibitor peptide (14-22) of PKA (100 μM) reduced the protective effect of cAMP on LT-induced Lp increase in vivo and gap formation in vitro, indicating that the effect of cAMP on Rac-1 inhibition was PKA dependent. Glucosylation assays demonstrated that cAMP prevents inhibitory Rac-1 glucosylation by LT, indicating that one way that cAMP enhances endothelial barrier functions may be by regulating Rac-1 signaling. Our study suggests that cAMP may provide its well-established protective effects at least in part by regulation of Rho proteins.

KW - cAMP-dependent protein kinase

KW - Permeability

KW - Rho proteins

KW - Vascular endothelial cadherin

UR - http://www.scopus.com/inward/record.url?scp=9344263492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344263492&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00556.2004

DO - 10.1152/ajpheart.00556.2004

M3 - Article

C2 - 15271660

AN - SCOPUS:9344263492

VL - 287

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6 56-6

ER -